7 February 2023 in Laboratory Investigation
Patient-derived tumor organoids have considerable potential as an in vitro diagnostic tool for drug susceptibility testing. In the present study, we investigated whether bile collected for diagnostic purposes could be a potential source for the establishment of biliary cancer organoids. Among 68 cases of biliary cancer, we successfully generated 60 bile-derived organoids (BDOs) from individual patients. Consistent with previous reports that described biliary cancer organoids from surgical tissues, the BDOs showed diverse morphologies such as simple cysts, multiloculated cysts, thick capsulated cysts, and solid masses. They also harbored mutations in KRAS and TP53 at frequencies of 15% and 55%, respectively. To enrich the cancer organoids by removing contaminated noncancerous components of BDOs, we attempted to verify the effectiveness of 3 different procedures, including repeat passage, xenografting, and selection with an MDM2 inhibitor for TP53 mutation-harboring BDOs. By monitoring the sequence and expression of mutated TP53, we found that all these procedures successfully enriched the cancer organoids. Our data suggest that BDOs can be established with minimal invasiveness from almost all patients with biliary cancers, including inoperable cases. Thus, despite some limitations with respect to the characterization of BDOs and methods for the enrichment of cancer cell-derived organoids, our data suggest that BDOs have potential applications in personalized medicine.
3 March 2020 in Clinical Journal of Gastroenterology
Gastrointestinal Dieulafoy’s ulcer is a rare disease of unknown etiology. Dieulafoy’s ulcer often presents in the stomach and is thought to cause about 5% of all gastrointestinal bleeds in adults, but can be found in any part of the gastrointestinal tract. Dieulafoy’s ulcer corresponds to an arterial malformation in the submucosal space and can cause life-threatening hemorrhage. We report a case of the lower gastrointestinal bleeding from a cecal Dieulafoy’s ulcer that was successfully treated with endoscopic clips. An 82-year-old woman had been diagnosed with hypertension and cerebral infarction. She had been using aspirin to prevent recurrent infarction. She was admitted to our hospital with hematochezia. Urgent colonoscopy revealed a small, reddish vascular malformation in the cecum. The lesion was suggestive of Dieulafoy’s ulcer and was treated with endoscopic clips. The patient has since been discharged from our hospital without experiencing any further bleeding. Endoscopy is a useful method for diagnosing and treating Dieulafoy’s ulcer.
25 March 2021 in Clinical Journal of Gastroenterology
20 December 2022 in DEN Open
A 74‐year‐old man was diagnosed with unresectable pancreatic cancer with obstructive jaundice. Chemotherapy with gemcitabine and nab‐paclitaxel was initiated after placement of a duckbill‐shaped anti‐reflux metal stent (D‐ARMS). A period of 1 month after D‐ARMS placement, the patient developed hematemesis and entered severe shock following emergency admission for further evaluation.Contrast‐enhanced computed tomography revealed a pseudoaneurysm in the gastroduodenal artery, coincident with the site of D‐ARMS placement, and bleeding from the same site was diagnosed. Angiography was performed, and the pseudoaneurysm was successfully treated by transcatheter arterial embolization using coils. The patient was subsequently discharged from hospital and experienced no further bleeding until his death due to an aggravation of the pancreatic cancer after 2 months. We report a case of pancreatic cancer with pseudoaneurysm after D‐ARMS placement.
22 November 2025 in DEN Open
Objectives: Pancreatic fluid collections (PFCs) are able to develop secondary to either fluid leakage or liquefaction of acute pancreatitis, chronic pancreatitis, pancreatic trauma, or after pancreatic surgery. While most PFCs resolve spontaneously, endoscopic procedures are sometimes necessary. Endoscopic ultrasound‐guided transluminal drainage (EUS‐TD) using lumen‐apposing metal stents (LAMS) is now widely performed for PFCs. This study investigated the incidence of complications and points to be considered during and after EUS‐TD using LAMS for the treatment of patients with PFCs. Methods: This three‐center retrospective study investigated patients who underwent EUS‐TD using LAMS or using a double‐pigtail plastic stent (DPS) for the treatment of PFCs at the University of Oita Hospital and affiliated institutions from December 2018 to June 2024. The primary outcome was the clinical success rate. Secondary outcomes included the technical success rate, endoscopic procedure time, LAMS indwell term, adverse events (AEs), and post‐LAMS placement course. Results: Twenty‐five patients (mean age, 67.5 ± 15.4 years; 76% male) underwent LAMS placement for PFCs. Median size of PFCs was 90 mm (range, 40–227 mm). A clinical success rate was achieved in 96%. The technical success rate was 96%, and the median endoscopic procedure time was 11 min (range, 5–32 min). Median LAMS indwell term was 46 days (range, 36‐60 days). AEs were bleeding and stent migration. Post‐LAMS placement course was good in 22 patients. No patients required re‐treatment after LAMS removal. Conclusions: EUS‐TD using LAMS is a simple procedure for the treatment of PFCs and appears clinically effective, highly safe, and efficient compared to conventional EUS‐TD using DPS.